(redirected from Hemodialysis access)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial.


The filtering of toxic solutes and excess fluid from the blood via an external membranous coil placed between the blood and a rinsing solution.



a method of extrarenal purification of the blood in acute and chronic renal insufficiency. During dialysis, toxic metabolic products are removed from the body, and the impaired water and electrolyte balances are normalized. Dialysis is effected by exchange transfusion of blood (simultaneous massive bloodletting with transfusion of the same amount of whole blood), by washing the peritoneum with a salt solution (peritoneal dialysis), and by washing the intestinal mucosa with moderately hypertonic solutions (intestinal dialysis). Use of an artificial kidney is the most effective method of dialysis.


References in periodicals archive ?
When speaking about her hemodialysis access catheter, Mrs.
Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients.
9 February 2011 - US Pervasis Therapeutics Inc said yesterday that the US Food and Drug Administration (FDA) has granted Fast Track review status for Vascugel for the prevention of hemodialysis access failure in patients with end stage renal disease (ESRD).
Janet Graham (Access Coordinator) is providing monthly in-services regarding hemodialysis access questions and concerns.
Other topics include the clinical application of noninvasive vascular imaging, magnetic resonance angiography, hemodialysis access, and bypass grafts.
Sodemann, used catheter locking solution in 70 patients with the company's Dialock Hemodialysis Access System.
High-pressure PTA balloons are used to keep hemodialysis access sites open for dialysis treatments, to restore blood flow in the legs, to dilate narrowings in renal (kidney) arteries, and dilate lesions in other vessels throughout the body.
Associations between hemodialysis access type and clinical outcomes: A systematic review.
We will continue to work closely with the FDA to ensure the most efficient review process as we advance the development of HumaGraft for patients needing hemodialysis access.